Metraipolis › archive › dc_3e7f308bccf5

Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42746314
DOI
10.7759/cureus.116274
License (as archived)
solo-consultazione
Archived
2026-10-10T02:13:39.933Z
SHA-256 of the archived text
8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9
Stable URL of this page
https://metraipolis.com/documento/dc_3e7f308bccf5

How to cite

Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314 — Europe PMC (en), https://europepmc.org/article/MED/42746314 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e7f308bccf5 (Metraipolis archive dc_3e7f308bccf5, sha256 8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9)
BibTeX
@misc{dc3e7f308bccf5,
  title = {Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42746314},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e7f308bccf5; sha256 8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746314. Agents can read the archived copy with the MCP tool read_document.